PTK2B and colorectal cancer: In these studies, PTK/ZK (vatalanib), an oral inhibitor of VEGF receptors, was used in combination with chemotherapy (FOLFOX) for, respectively, first- and second-line therapy of advanced colorectal cancer (Hecht et al, 2011; Van Cutsem et al, 2011).